CNCR
Range Cancer Therapeutics ETF
ETF Series Solutions
ETFIndex fund

Average annual returns

Through 2024 · incl. N-PORT-derived 2024
1 year
-9.00%
3 year
-19.64%
5 year
10 year

Standardized average annual total returns (before tax), from calendar-year returns; recent years derived from N-PORT monthly data.

Calendar-year returns

2021 onward derived from N-PORT monthly returns

Risk statistics

60 months through Feb. 28, 2025
Volatility (ann.)
31.17%
Sharpe
-0.48
Sortino
-0.71
Max drawdown
-67.87%
Best month
22.96%
Worst month
-18.25%
Beta vs VTSAX
0.91
Correlation
0.51

Derived from N-PORT monthly total returns; distinct from the prospectus returns above.

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.